SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs shines on obtaining new product registration

12 Feb 2018 Evaluate

Vivimed Labs is currently trading at Rs. 87.00, up by 1.55 points or 1.81% from its previous closing of Rs. 85.45 on the BSE.

The scrip opened at Rs. 85.15 and has touched a high and low of Rs. 88.45 and Rs. 85.15 respectively. So far 75601 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 153.30 on 21-Sep-2017 and a 52 week low of Rs. 75.00 on 06-Feb-2018.

Last one week high and low of the scrip stood at Rs. 89.45 and Rs. 75.00 respectively. The current market cap of the company is Rs. 718.78 crore.

The promoters holding in the company stood at 35.81%, while Institutions and Non-Institutions held 10.14% and 54.05% respectively.

Vivimed Labs’ Unit 1 FDF manufacturing facility located in Hyderabad, post certification by Ukraine FDA, has successfully registered 8 products in anti viral, pain management and cough suppressants segment.

The company has now inked a distribution agreement with ‘Alter Ego LLC’, Kieve, Ukraine which has more than a decade of presence in Ukraine, Russia and CIS regions. The company is expecting revenues upwards of $10 million for FY19 from CIS region.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.


Vivimed Labs Share Price

7.79 0.37 (4.99%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×